{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:43:04Z","timestamp":1767991384849,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Municipal Natural Science Foundation","award":["7222094"],"award-info":[{"award-number":["7222094"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To explore the effect of dynamic changes in free triiodothyronine (FT3) level for predicting the 90\u00a0day prognosis of patients with hepatitis B virus\u2013related acute-on-chronic liver failure (HBV-ACLF).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The clinical data of 122 hospitalised patients with HBV-ACLF between September 2018 and January 2020 were collected and divided into a survival group (77 cases) and a death group (45 cases) according to the 90\u00a0day prognosis. We statistically analysed the characteristics of FT3 changes in the two groups of patients. Binary logistic regression one-way analysis was used to assess the degree of influence of each factor. The Kaplan\u2013Meier survival curve and receiver operating characteristic curve were used to evaluate the effect of a single change in FT3 level difference (single \u25b3FT3) and the FT3 level change range (\u25b3FT3 range) in predicting the 90-day prognosis of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were only three types of changes in FT3 levels, which included 19 (15.6%) cases of continuous normal type, 35 (28.7%) cases of continuous decrease type and 68 (55.7%) cases of U-shaped change type. The difference in survival curves between the three types of patients was statistically significant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The dynamic change type of FT3 is related to the disease severity and 90-day prognosis of patients with HBV-ACLF. The single FT3 value and FT3 range could be used as a predictive factor for the 90-day prognosis of patients with HBV-ACLF. These results have a degree of research value and are worth further exploration in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-024-01770-2","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T14:03:01Z","timestamp":1715781781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The value of dynamic changes in FT3 level for predicting 90-day prognosis of HBV-ACLF patients"],"prefix":"10.1186","volume":"29","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"issue":"22","key":"1770_CR1","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","volume":"382","author":"V Arroyo","year":"2020","unstructured":"Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137\u201345. https:\/\/doi.org\/10.1056\/NEJMra1914900.","journal-title":"N Engl J Med"},{"issue":"6","key":"1770_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/jgh3.12557","volume":"5","author":"B Valantine","year":"2021","unstructured":"Valantine B, Sundaray N, Mishra D, Sahu S, Narayan J, Panda N, B, et al. Predictors of early mortality among patients with acute-on-chronic liver failure. JGH Open. 2021;5(6):686\u201394. https:\/\/doi.org\/10.1002\/jgh3.12557.","journal-title":"JGH Open"},{"key":"1770_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.692669","volume":"8","author":"JF Chen","year":"2021","unstructured":"Chen JF, Weng WZ, Huang M, Peng XH, He JR, Zhang J, et al. Derivation and validation of a nomogram for predicting 90\u00a0day survival in patients with HBV-related acute-on-chronic liver failure. Front Med. 2021;8: 692669. https:\/\/doi.org\/10.3389\/fmed.2021.692669.","journal-title":"Front Med"},{"issue":"24","key":"1770_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007142","volume":"96","author":"B Chen","year":"2017","unstructured":"Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine. 2017;96(24): e7142. https:\/\/doi.org\/10.1097\/MD.0000000000007142.","journal-title":"Medicine"},{"issue":"4","key":"1770_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/17474124.2018.1426459","volume":"12","author":"RH Zhao","year":"2018","unstructured":"Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. Acute-on-chronic liver failure in chronic hepatitis B: an update. Exp Rev Gastroenterol Hepatol. 2018;12(4):341\u201350. https:\/\/doi.org\/10.1080\/17474124.2018.1426459.","journal-title":"Exp Rev Gastroenterol Hepatol"},{"issue":"1","key":"1770_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12876-020-01191-5","volume":"20","author":"Y Hou","year":"2020","unstructured":"Hou Y, Zhang Q, Gao F, Mao DW, Li J, Gong ZJ, et al. Artificial neural network-based models used for predicting 28 and 90\u00a0day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC Gastroenterol. 2020;20(1):75. https:\/\/doi.org\/10.1186\/s12876-020-01191-5.","journal-title":"BMC Gastroenterol"},{"issue":"25","key":"1770_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020604","volume":"99","author":"R Gao","year":"2020","unstructured":"Gao R, Li Y, Cao Y, Zheng RJ, Tang L, Yang JZ, et al. Glucocorticoid versus traditional therapy for hepatitis B virus\u2013related acute-on-chronic liver failure: a systematic review and meta-analysis. Medicine. 2020;99(25): e20604. https:\/\/doi.org\/10.1097\/MD.0000000000020604.","journal-title":"Medicine"},{"issue":"1","key":"1770_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146745","volume":"11","author":"TY Kim","year":"2016","unstructured":"Kim TY, Song DS, Kim HY, Sinn DH, Yoon EL, Kim CW, et al. Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition. PLoS One. 2016;11(1): e0146745. https:\/\/doi.org\/10.1371\/journal.pone.0146745.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"1770_CR9","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jhep.2020.11.047","volume":"75","author":"R Moreau","year":"2021","unstructured":"Moreau R, Gao B, Papp M, Ba\u00f1ares R, Kamath PS. Acute-on-chronic liver failure: a distinct clinical syndrome. J Hepatol. 2021;75(Suppl 1):S27-s35. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.047.","journal-title":"J Hepatol"},{"issue":"1","key":"1770_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/s41598-021-81431-0","volume":"11","author":"Z Yu","year":"2021","unstructured":"Yu Z, Zhang Y, Cao Y, Xu MM, You SL, Chen Y, et al. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators. Sci Rep. 2021;11(1):1810. https:\/\/doi.org\/10.1038\/s41598-021-81431-0.","journal-title":"Sci Rep"},{"issue":"1","key":"1770_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.dld.2019.08.013","volume":"52","author":"G Pereira","year":"2020","unstructured":"Pereira G, Baldin C, Piedade J, Reis V, Valdeolivas T, Victor L, et al. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Dig Liver Dis. 2020;52(1):91\u20137. https:\/\/doi.org\/10.1016\/j.dld.2019.08.013.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"1770_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12072-017-9816-z","volume":"11","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11(5):461\u201371. https:\/\/doi.org\/10.1007\/s12072-017-9816-z.","journal-title":"Hepatol Int"},{"issue":"1","key":"1770_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/hep.27849","volume":"62","author":"T Gustot","year":"2015","unstructured":"Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243\u201352. https:\/\/doi.org\/10.1002\/hep.27849.","journal-title":"Hepatology"},{"issue":"5","key":"1770_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.CIR.0000048124.64204.3F","volume":"107","author":"G Iervasi","year":"2003","unstructured":"Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107(5):708\u201313. https:\/\/doi.org\/10.1161\/01.CIR.0000048124.64204.3F.","journal-title":"Circulation"},{"issue":"3","key":"1770_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1586\/14737175.2015.1013465","volume":"15","author":"A Bunevicius","year":"2015","unstructured":"Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother. 2015;15(3):315\u201326. https:\/\/doi.org\/10.1586\/14737175.2015.1013465.","journal-title":"Expert Rev Neurother"},{"key":"1770_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.12659\/MSM.895953","volume":"22","author":"J Fan","year":"2016","unstructured":"Fan J, Yan P, Wang Y, Shen B, Ding F, Liu Y. Prevalence and clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monitor. 2016;22:1171\u20139. https:\/\/doi.org\/10.12659\/MSM.895953.","journal-title":"Med Sci Monitor"},{"issue":"3","key":"1770_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/MAJ.0b013e318239a666","volume":"344","author":"A Ta","year":"2012","unstructured":"Ta A, Koklu S, Beyazit Y, Kert M, Sayilir A, Yesil Y, et al. Thyroid hormone levels predict mortality in intensive care patients with cirrhosis. Am J Med Sci. 2012;344(3):175\u20139. https:\/\/doi.org\/10.1097\/MAJ.0b013e318239a666.","journal-title":"Am J Med Sci"},{"key":"1770_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8857906","volume":"2020","author":"X Wang","year":"2020","unstructured":"Wang X, Mao J, Zhou X, Li Q, Gao L, Zhao J. Thyroid stimulating hormone triggers hepatic mitochondrial stress through cyclophilin D acetylation. Oxid Med Cell Longev. 2020;2020:1\u201312.","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1770_CR19","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/apt.14927","volume":"48","author":"D Wu","year":"2018","unstructured":"Wu D, Sun Z, Liu X, Rao Q, Chen W, Wang J, et al. HINT: a novel prognostic model for patients with hepatitis B virus\u2013related acute-on-chronic liver failure. Aliment Pharmacol Ther. 2018;48(7):1426\u201337. https:\/\/doi.org\/10.1111\/apt.14927.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1770_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1665-2681(19)30784-7","volume":"14","author":"Y Wu","year":"2015","unstructured":"Wu Y, You S, Zang H, Liu H, Mao Y, Mao P, et al. Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-Chronic liver failure. Ann Hepatol. 2015;14(2):218\u201324. https:\/\/doi.org\/10.1016\/S1665-2681(19)30784-7.","journal-title":"Ann Hepatol"},{"issue":"6","key":"1770_CR21","first-page":"401","volume":"11","author":"Liver Failure and Artificial Liver Group of Infectious Diseases Branch of Chinese Medical Association","year":"2018","unstructured":"Liver Failure and Artificial Liver Group of Infectious Diseases Branch of Chinese Medical Association. Severe Liver Disease and Artificial Liver Group of Chinese Hepatology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of liver failure (2018 edition). Chin J Clin Infect Dis. 2018;11(6):401\u201310.","journal-title":"Chin J Clin Infect Dis"},{"key":"1770_CR22","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-5069.2020.01.044","author":"Chinese Society of Infectious Diseases, Chinese Medical Association Chinese Society of Hepatology, Chinese Medical Association","year":"2020","unstructured":"Chinese Society of Infectious Diseases, Chinese Medical Association Chinese Society of Hepatology, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). J Pract Hepatol. 2020. https:\/\/doi.org\/10.3969\/j.issn.1672-5069.2020.01.044.","journal-title":"J Pract Hepatol"},{"key":"1770_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.821746","volume":"13","author":"S Qiao","year":"2022","unstructured":"Qiao S, Zhang SC, Zhang RR, et al. Thyroid function and low free triiodothyronine in Chinese patients with autoimmune encephalitis. Front Immunol. 2022;13: 821746. https:\/\/doi.org\/10.3389\/fimmu.2022.821746.","journal-title":"Front Immunol"},{"issue":"5","key":"1770_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/HMER.S9049.eCollection","volume":"2013","author":"T Lau","year":"2013","unstructured":"Lau T, Ahmad J. Clinical applications of the model for end-stage liver disease (MELD) in hepatic medicine. Hepat Med. 2013;2013(5):1\u201310. https:\/\/doi.org\/10.2147\/HMER.S9049.eCollection.","journal-title":"Hepat Med"},{"issue":"30","key":"1770_CR25","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3748\/wjg.v26.i30.4479","volume":"26","author":"C Zhou","year":"2020","unstructured":"Zhou C, Zhang N, He TT, Wang Y, Wang LF, Sun YQ, et al. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2020;26(30):4479\u201388. https:\/\/doi.org\/10.3748\/wjg.v26.i30.4479.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1770_CR26","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.1074\/jbc.M114.600312","volume":"290","author":"YY Liu","year":"2015","unstructured":"Liu YY, Ayers S, Milanesi A, Teng XC, Rabi S, Akiba Y, et al. Thyroid hormone receptor sumoylation is required for preadipocyte differentiation and proliferation. J Biol Chem. 2015;290(12):7402\u201315. https:\/\/doi.org\/10.1074\/jbc.M114.600312.","journal-title":"J Biol Chem"},{"key":"1770_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.metabol.2016.11.002","volume":"67","author":"EH Van Den Berg","year":"2017","unstructured":"Van Den Berg EH, Van Tienhoven-Wind LJ, Amini M, Schreuder TCMA, Faber KN, Blokzijl H, et al. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the lifelines cohort study. Metabolism. 2017;67:62\u201371. https:\/\/doi.org\/10.1016\/j.metabol.2016.11.002.","journal-title":"Metabolism"},{"issue":"3","key":"1770_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jjcc.2018.02.013","volume":"72","author":"W Su","year":"2018","unstructured":"Su W, Zhao XQ, Wang M, Chen H, Li HW. Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction. J Cardiol. 2018;72(3):215\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2018.02.013.","journal-title":"J Cardiol"},{"issue":"6","key":"1770_CR29","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.jhep.2014.06.042","volume":"61","author":"D Agiasotelli","year":"2014","unstructured":"Agiasotelli D, Alexopoulou A, Vasilieva L, Dourakis SP. Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure. J Hepatol. 2014;61(6):1446\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.042.","journal-title":"J Hepatol"},{"key":"1770_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.21037\/tgh.2019.09.11","volume":"4","author":"AK Singal","year":"2019","unstructured":"Singal AK, Kamath PS. Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. Transl Gastroenterol Hepatol. 2019;4:74. https:\/\/doi.org\/10.21037\/tgh.2019.09.11.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"1","key":"1770_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ajg.2016.479","volume":"112","author":"A Floreani","year":"2017","unstructured":"Floreani A, Mangini C, Reig A, Franceschet I, Cazzagon N, Perini L, et al. Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European centers. Am J Gastroenterol. 2017;112(1):114\u20139. https:\/\/doi.org\/10.1038\/ajg.2016.479.","journal-title":"Am J Gastroenterol"},{"key":"1770_CR32","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-5256.2012.03.012","author":"B Yang","year":"2012","unstructured":"Yang B, Wu YK, Chen ZC, Gao ZL, Chong YT, Xie SB. The dynamic changes of AST, ALT, TBil and PT and their relationship with prognosis of acute-on-chronic hepatitis B liver failure. J Clin Hepatol. 2012. https:\/\/doi.org\/10.3969\/j.issn.1001-5256.2012.03.012.","journal-title":"J Clin Hepatol"},{"issue":"1","key":"1770_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12876-020-01437-2","volume":"20","author":"L Qiang","year":"2020","unstructured":"Qiang L, Qin J, Sun C, Sheng YJ, Chen W, Qiu BD, et al. A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol. 2020;20(1):301. https:\/\/doi.org\/10.1186\/s12876-020-01437-2.","journal-title":"BMC Gastroenterol"},{"issue":"33","key":"1770_CR34","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.3748\/wjg.v26.i33.5022","volume":"26","author":"A Bannaga","year":"2020","unstructured":"Bannaga A, Arasaradnam RP. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: a systematic review. World J Gastroenterol. 2020;26(33):5022\u201349. https:\/\/doi.org\/10.3748\/wjg.v26.i33.5022.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1770_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170394","volume":"12","author":"DH Lee","year":"2017","unstructured":"Lee DH, Lee JH, Jung YJ, Gim J, Kim W, Kim BG, et al. Validation of a modified child-turcotte-pugh classification system utilizing insulin-like growth factor-1 for patients with hepatocellular carcinoma in an HBV endemic area. PLoS One. 2017;12(1): e0170394. https:\/\/doi.org\/10.1371\/journal.pone.0170394.","journal-title":"PLoS One"},{"issue":"7","key":"1770_CR36","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Angeli P, Cordoba J, Durand F, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u201337. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.042.","journal-title":"Gastroenterology"},{"issue":"4","key":"1770_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353\u201390. https:\/\/doi.org\/10.1007\/s12072-019-09946-3. (Epub 2019 Jun 6).","journal-title":"Hepatol Int"},{"issue":"3","key":"1770_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3969\/j.issn.1001-5256.2018.03.021","volume":"34","author":"L Zhang","year":"2018","unstructured":"Zhang L, Chen W, Sheng YJ, Deng CL. Value of model for end-stage liver disease score combined with neutrophil\u2013lymphocyte ratio in predicting the short-term prognosis of patients with HBV-related acute-on-chronic liver failure. J Clin Hepat. 2018;34(3):5. https:\/\/doi.org\/10.3969\/j.issn.1001-5256.2018.03.021.","journal-title":"J Clin Hepat"},{"issue":"1","key":"1770_CR39","first-page":"48","volume":"26","author":"WW Wang","year":"2012","unstructured":"Wang WW, Guo JC, Li CQ, Xun YH, Wang YF, Yu XL, et al. The value of end-stage liver disease model dynamic score in evaluating the prognosis of HBV-related liver failure. Chin J Exp Clin Virol. 2012;26(1):48.","journal-title":"Chin J Exp Clin Virol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-01770-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T14:06:23Z","timestamp":1715781983000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-01770-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-01770-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"3 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the declaration of Helsinki.This study was conducted with approval from the Ethics Committee of Xuanwu Hospital of Capital Medical University.Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is not submitted for publication or consideration elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}